AMENDMENT #2 Compound Pharmaceuticals for Dept of Pharmacy, Carl R. Darnall Army Medical Center, Fort Hood, Tx.

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

W40M MRC0 WEST

Contract Value

Not provided

Codes & Classification
Solicitation Number

W81K0026QA064

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

SBA

Place of Performance

Texas, UNITED STATES

SourceSAM
Documents3
This solicitation, titled "AMENDMENT #2 Compound Pharmaceuticals for Dept of Pharmacy, Carl R. Darnall Army Medical Center, Fort Hood, Tx.," represents an active procurement opportunity issued by the Department of the Army under the Department of Defense. The notice, identified by procurement number W81K0026QA064, seeks to engage qualified contractors in the manufacturing and supply of compound pharmaceuticals to support the Department of Pharmacy at the Carl R. Darnall Army Medical Center, located at Fort Hood, Texas. The primary objective of this procurement is to ensure the reliable provision of compounded pharmaceutical preparations, which are essential for the ongoing healthcare operations at the medical center. The scope of work likely encompasses the formulation, preparation, and timely delivery of pharmaceutical compounds tailored to the specific needs of the medical facility, in compliance with all applicable regulatory standards and quality requirements. The intended outcome is to maintain a consistent and high-quality supply chain for critical medications, thereby supporting the medical readiness and care of military personnel and beneficiaries served by the center. This opportunity is classified under NAICS code 325412 (Pharmaceutical Preparation Manufacturing, 2022 version) and Product Service Code 6505, indicating a focus on the manufacturing and supply of pharmaceutical products. The procurement is set aside for SBA-eligible entities, reflecting a commitment to supporting small business participation in federal contracting. The place of performance is specified as Texas, United States, with all services and deliveries to be executed within this geographic area. The contracting activity is managed by W40M MRC0 WEST, a federal office under the Department of the Army. Interested parties are encouraged to review the solicitation and its amendments in detail, as the notice references the posting of Amendment #2 and includes three attachments available via the official SAM.gov opportunity listing. Key contacts for this procurement include Sheryl Egans ([email protected], 254-287-8881) and Sara Craig ([email protected], 254-285-6743), who can provide further information regarding the solicitation and its requirements. Contractors considering this opportunity should ensure their capabilities align with the manufacturing and supply of compounded pharmaceuticals, adherence to federal and state regulations, and the ability to meet the operational needs of a large military medical center. The procurement remains active, with a response deadline of December 2, 2026. For full details, including all amendments and attachments, interested vendors should consult the official notice at: https://sam.gov/opp/e5dd5c0d41ea43799b4327dee7a3b9f1/view.